series-a
Stage
2020
Founded
1
Investors
About
Trio Pharmaceuticals is a preclinical-stage biopharmaceutical company developing next-generation bifunctional antibody-drug conjugates (ADCs) to treat hard-to-treat cancers.
Explore Trio Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.